糖氧化单疗法用于印度慢性病患者的高酸血症进行血液透析:一个第四阶段,单臂,开放标签研究
M R Niranjan1, Sanjay Srinivasa2, Vibhanshu Gupta3
1Department of Nephrology, Mysore Medical College and Research Institute, Mysore 570001, Karnātaka, India.
World journal of nephrology
|June 26, 2025
概括
糖氧化 (SO) 有效降低了印度血液透析患者慢性病 (CKD) 的水平. 这项研究发现,SO是一种安全有效的高酸血症 (HP) 单疗法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 过血症 (HP) 是晚期慢性病 (CKD) 的普遍并发症,与不良的心血管和骨健康结果有关.
- 酸盐结合剂对于透析患者的HP管理至关重要.
- 糖氧化 (SO) 是一种基于铁的,无的口服酸盐结合剂,用于HP治疗.
研究的目的:
- 评估糖氧化 (SO) 可片在接受血液透析的印度慢性病患者中的疗效,安全性和耐受性.
- 评估SO在12周治疗期间对血清水平的影响.
主要方法:
- 这是一项为期12周的开放标签,单臂,多中心的第四期研究 (SOLO CKD),涉及印度血液透析患者.
- 患者每天接受1500毫克的SO可片.
- 在基线和随访期间测量血清含量;统计分析包括ANOVA和配对测试 (P<0.05显著).
主要成果:
- 该研究招募了114名患者,其中94人完成了12周的治疗.
- 平均血清含量显著下降,从基线的7.62 ± 2.02 mg/dL降至治疗后的5.13 ± 1.88 mg/dL (P < 0.05).
- 在33.33%的患者中报告了不良事件 (恶心,鼻炎,头痛),被认为与SO无关;没有发生严重的不良事件或停止治疗.
结论:
- 糖氧化 (SO) 在降低血清含量方面表现出显著的有效性,在接受血液透析的印度CKD患者中.
- 发现SO是一种安全有效的单一疗法,用于在现实环境中管理高酸血症 (HP).
- 该研究的结果表明,SO是一种可行的治疗选择,尽管样本规模很小,但在概括性方面需要谨慎解释.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84
01:18Chronic Kidney Disease IV: Nursing Management
61
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
61
01:25Hemodialysis III: Nursing Management
215
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
215
01:11Renal Failure: Dose Adjustments
167
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
167
01:24Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
01:24Hemodialysis II: Procedure and Complications
146
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
146